These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38214526)

  • 1. Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study.
    Leong DP; Loeb M; Mony PK; Rangarajan S; Mushtaha M; Miller MS; Dias M; Yegorov S; V M; Telci Caklili O; Temizhan A; Szuba A; Abat MEM; Mat-Nasir N; Diaz ML; Khansaheb H; Lopez-Jaramillo P; Duong M; Teo KK; Poirier P; Oliveira G; Avezum Á; Yusuf S
    Microbiol Spectr; 2024 Feb; 12(2):e0149223. PubMed ID: 38214526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
    Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
    J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study.
    Doucette EJ; Gray J; Fonseca K; Charlton C; Kanji JN; Tipples G; Kuhn S; Dunn J; Sayers P; Symonds N; Wu G; Freedman SB; Kellner JD
    PLoS One; 2023; 18(4):e0284046. PubMed ID: 37023007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response.
    Cerbino-Neto J; Peres IT; Varela MC; Brandão LGP; de Matos JA; Pinto LF; da Costa MD; Garcia MHO; Soranz D; Maia MLS; Krieger MA; da Cunha RV; Camacho LAB; Ranzani O; Hamacher S; Bozza FA; Penna GO
    Front Public Health; 2022; 10():1017337. PubMed ID: 36457326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
    Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
    BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.
    Li Y; Tong CH; Bare LA; Devlin JJ
    JAMA Netw Open; 2021 May; 4(5):e2111634. PubMed ID: 34009346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
    Bansal A; Trieu MC; Mohn KGI; Madsen A; Olofsson JS; Sandnes HH; Sævik M; Søyland H; Hansen L; Onyango TB; Tøndel C; Brokstad KA; ; Syre H; Riis ÅG; Langeland N; Cox RJ
    Front Public Health; 2023; 11():1164326. PubMed ID: 37546332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020.
    Munywoki PK; Nasimiyu C; Alando MD; Otieno N; Ombok C; Njoroge R; Kikwai G; Odhiambo D; Osita MP; Ouma A; Odour C; Juma B; Ochieng CA; Mutisya I; Ngere I; Dawa J; Osoro E; Njenga MK; Bigogo G; Munyua P; Lo TQ; Hunsperger E; Herman-Roloff A
    F1000Res; 2021; 10():853. PubMed ID: 35528961
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroepidemiology in Mongolia, 2020-2021: a longitudinal national study.
    Chimeddorj B; Bailie CR; Mandakh U; Price DJ; Bayartsogt B; Meagher N; Altanbayar O; Magvan B; Deleg Z; Gantumur A; Byambaa O; Nyamdavaa E; Enkhtugs K; Munkhbayar U; Bayanjargal B; Badamsambuu T; Dashtseren M; Amartuvshin T; Narmandakh Z; Togoo K; Boldbaatar EA; Bat-Erdene A; Chimeddorj U; Nyamdavaa K; Tsevegmid E; Batjargal O; Enebish O; Enebish G; Batchuluun B; Zulmunkh G; Byambatsogt G; Enebish T; Le LV; Bergeri I; McVernon J; Erkhembayar R
    Lancet Reg Health West Pac; 2023 Apr; 36():100760. PubMed ID: 37360871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign.
    Bartig S; Beese F; Wachtler B; Grabka MM; Mercuri E; Schmid L; Schmid-Küpke NK; Schranz M; Goßner L; Niehues W; Zinn S; Poethko-Müller C; Schaade L; Hövener C; Gößwald A; Hoebel J
    Int J Public Health; 2023; 68():1606152. PubMed ID: 37780135
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.
    Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N
    Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.